These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7853726)

  • 1. [LDL apheresis in the treatment of hyperlipoproteinemia].
    Ishikawa K
    Nihon Rinsho; 1994 Dec; 52(12):3298-302. PubMed ID: 7853726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
    Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
    Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
    Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
    Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal treatment of hypercholesterolaemia.
    Olbricht CJ
    Nephrol Dial Transplant; 1993; 8(9):814-20. PubMed ID: 8255513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
    Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
    Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL apheresis by dextran sulfate cellulose (DSC) column in two patients with monogenic familial hypercholesterolemia (FH).
    Aubert I; Bombail D; Erlich D; Goussault Y; Rouffy J; Bussel A
    Prog Clin Biol Res; 1990; 337():205-7. PubMed ID: 1693782
    [No Abstract]   [Full Text] [Related]  

  • 8. [LDL apheresis].
    Nakamura T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():707-14. PubMed ID: 11347159
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
    Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
    Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.
    Gordon BR; Kelsey SF; Bilheimer DW; Brown DC; Dau PC; Gotto AM; Illingworth DR; Jones PH; Leitman SF; Prihoda JS
    Am J Cardiol; 1992 Oct; 70(11):1010-6. PubMed ID: 1414897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid apheresis, indications, and principles.
    Winters JL
    J Clin Apher; 2011; 26(5):269-75. PubMed ID: 21834078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of combined LDL affinity apheresis utilizing dextran sulfate cellulose columns and hypolipidemic medications in patients with severe hypercholesterolemia to assess regression of atherosclerosis.
    Jones PH
    Beitr Infusionsther; 1988; 23():142-5. PubMed ID: 2484769
    [No Abstract]   [Full Text] [Related]  

  • 15. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K
    J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term effect of LDL apheresis on coronary heart disease.
    Donner MG; Richter WO; Schwandt P
    Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The extracorporeal elimination of LDL cholesterol by apheresis. The indications and methods].
    Olbricht CJ
    Dtsch Med Wochenschr; 1991 Apr; 116(16):625-30. PubMed ID: 2015780
    [No Abstract]   [Full Text] [Related]  

  • 19. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
    Mol MJ; Stalenhoef AF
    Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL cholesterol apheresis by dextran sulfate cellulose adsorption. Long-term experience in patients with familial hypercholesterolemia.
    Olbricht CJ; Schulzeck P
    ASAIO Trans; 1991; 37(3):M492-3. PubMed ID: 1751248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.